mRNA and protein expression of NDRG1 was found to be decreased in primary cancer and metastatic cells, including colon (15,16), prostate (17,18), breast (18) and esophageal squamous cancer (19), as well as glioma (20), as compared with that in normal cells. Here, NDRG1 is linked to glioma.